SPOTLIGHT -
Risk Factors Linked With Brain Complications in COVID-19 Patients
Commonly reported issues included delirium, encephalopathies and psychiatric complications.
Read More
Emphasizing Health Benefits May Increase COVID-19 Vaccination Rates
Public information campaigns may potentially boost rates of vaccination.
Second Dose of COVID-19 mRNA Vaccine Found Safe After Reaction to First
As much as 2% of vaccine recipients have reported anaphylaxis following their first shot.
CDC Announces New Mask Recommendations for Vaccinated Individuals Under Certain Circumstances
The agency is expected to make a statement later today on masking recommendations.
Response to COVID-19 in Nasopharynx May Determine Disease Severity
The nasal mucosa was seen to be an essential determinant of overall disease trajectory.
Modeling the True Prevalence of the COVID-19 Pandemic
The framework could help officials assess the true burden of disease in certain areas.
Antibodies Last at Least 9 Months After COVID-19 Infection
Modeling showed 1 in 4 infected people pass the infection to a family member.
Major Healthcare Organizations Call for COVID-19 Vaccine Mandates
The statement includes over 50 societies and organizations, representing millions of workers.
FDA Denies NDA for Iterum Therapeutics Oral Sulopenem
The company will review the CRL and request a Type A meeting in the coming weeks.
Increasing Protective Molecules May Limit COVID-19 Related Inflammation
Not much is known about the relationship between the expression and activity of SPM pathways and COVID-19 disease severity.
Candida Auris Confirmed to be Spreading in 2 US Cities
The clusters were identified in Washington, DC, and the Dallas area.
Increasing Family Physician Engagement with PrEP Therapy
Due to limited familiarity with providing antiretroviral medication, many participants were hesitant to initiate PrEP.
Severe COVID-19 Risk Factors for Younger Populations
Associations found in people under the age of 45 were weaker in patients over that age.
Malnutrition May Lead to More Severe COVID-19 Outcomes
Patients with a history of malnutrition had higher odds of developing severe disease.
Effectiveness of Pfizer, AstraZeneca COVID-19 Vaccines Against Delta Variant
While a significantly reduced effectiveness was seen with 1 dose, only a small reduction was observed after 2.
Resilience in People Living With HIV During the COVID-19 Pandemic
Impaired resilience was found to be associated with loneliness.
Providing Online HIV Services During the COVID-19 Pandemic
Virtual support services were crucial for providing continued care and education.
PrEP Use Low Among Individuals With Self-Reported HIV Risk Factors
Many respondents reported having a lack of information about the use of PrEP.
Those With HIV Have High Rates of COVID-19 Hospitalizations, Mortality
PLWH should strictly maintain ART therapy and COVID-19 mitigation efforts.
Promoting HIV Partner Notification Services Using a People-Centered Approach
Crowdsourcing and other approaches may develop more effective interventions to promote PS.
Exploring PrEP Implementation Factors in the Southern US
More tailored strategies could improve PrEP provision in family planning clinics.
CDC Confirms Case of Human Monkeypox in US Resident
The case was identified in an individual who had recently returned from a trip to Nigeria.
Impact of Home-Based Testing on Uptake and Knowledge of HIV Status
No significant difference was observed across the 3 study groups.
COVID-19 Humoral and T-Cell Immune Responses Among People Living With HIV
A positive relationship may exist between infection severity and adaptive immunity.
Do Adverse Childhood Experiences Impact PrEP Uptake in Young Adulthood?
Rates of testing for HIV, as well as PrEP uptake, remain suboptimal in MSM of color.
Those at High Risk Know about PrEP but Use Remains low
Results from the study highlight the importance of PrEP education in clinical settings.
Single Dose of Sputnik V Vaccine Triggers Strong Response
94% of the participants developed IgG antibodies against the virus 3 weeks after administration.
Blood Tests May Help Monitor SARS-CoV-2 Infection
Truncated ACE2 levels served to discriminate patients infected with SARS-CoV-2 and influenza A.
Janssen COVID-19 Vaccine Elicits Immune Response for At Least 8 Months
The Johnson & Johnson vaccine showed neutralizing antibody responses against variants of concern.
PrEP Use Disparities Worsening Between Early and Late Adopting States
PrEP use is estimated to prevent >90% of infections in men who have sex with men and 70% of infections in people who inject drugs.